Estamos no ar no !
Saiba mais
Anebulo Pharmaceuticals
Deslistada
ANEB foi retirado da bolsa em 27 de fevereiro de 2026.
Sobre: Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
Funcionários: 3
Notícias
Positivo
Neutro
Negativo
Sentimento
3 meses
Positivo
0%
Neutro
0%
Negativo
0%
Gráficos de preços implementados com Lightweight Charts™